Patent · US Active

Substituted piperaziniums for the treatment of emesis

US10717721B2 · kind B2 · utility

0Cited by

12References

2Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Luca Fadini · Giubiasco, CH
Peter Manini · Giubiasco, CH
Claudio Pietra · Como, IT
Claudio Giuliano · Como, IT
Emanuela Lovati · Mendrisio, CH
Roberta Cannella · Varese, IT
Alessio Venturini · Varese, IT
Valentino J. Stella · Lawrence, US

Key dates

Filing date	Dec 21, 2018
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Dec 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/650952
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK1) receptor. The compounds have the general formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.